Navigation Links
Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
Date:5/22/2013

WORCESTER, Mass. and TORONTO, May 22, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced three presentations demonstrating the superiority of the AE37 breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago from May 31 through June 4, 2013.

The presentation entitled "Booster inoculations of the AE37 peptide vaccine enhance immunological responses in a phase II study", by Eleftheria Anastasopoulou et al, demonstrates that increased immunological responses observed after the initial series of inoculations with AE37 can be further increased over a 24 month period in patients receiving boosters every six months.  The AE37 vaccine is a combination of a fragment of the HER2 protein plus a proprietary modification developed by Antigen Express scientists.

The presentation entitled "Risk factors for development of delayed urticarial reactions in the phase II trial of HER2 peptide vaccines plus GM-CSF versus GM-CSF alone in high-risk breast cancer patients to prevent recurrence", by Alfred Trappey et al, demonstrates that the only side effects are associated with the GM-CSF adjuvant rather than the AE37 peptide and are entirely manageable.

A third online abstract entitled "Effect of immunization with Ii-Key modified HER2 (776-790) peptide vaccine (AE37) on immunologic responses in prostate cancer patients", by Sonia Perez et al, demonstrates long-term immunological response to AE37 in prostate cancer patients in the absence of booster administrat
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Touts Pipeline Potential of Antigen Express Subsidiary
2. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
3. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
4. Generex Announces Details of Investor Conference Call
5. Generex Addresses Recent Trading Volume in Shares of its Common Stock
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
8. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
9. Generex Augments Antigen Express Scientific Advisory Board
10. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
11. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
(Date:7/29/2014)... , July 29, 2014 Numotion,s Board of Directors ... Swinford will be the company,s new Chief Executive Officer. ... 22-year career at GE where he worked primarily for GE ... revenue to over $5 billion. His most recent position was ... "I am thrilled to join Numotion," said ...
(Date:7/29/2014)... and NEW YORK , July 29, ... executive management team of Caremark Rx, Drew Crawford ... www.pbm365.com ).  PBM365 is the leading independent media source ... insight, analysis and opinion on the pharmacy benefit management ... insightful and timely coverage of, and context behind, industry ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Numotion Names Mike Swinford CEO 2Drew Crawford Announces Launch of PBM365 Media 2
... K-V Pharmaceutical Company ( KVa; KVb) (the "Company") ... HOLX ) that site initiation and patient enrollment has ... in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 ... of preterm birth in women pregnant with a single baby ...
... The Wireless-Life Sciences Alliance (WLSA) , which convenes innovators, globally relevant ... in wireless technologies, today hailed its partner organizations for their collaboration and ... , , ... , , ...
Cached Medicine Technology:K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 2K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 3K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 4K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 5K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 6K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 7K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 8K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 9Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 2Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 3
(Date:7/29/2014)... July 29, 2014 Biocides are chemical ... control bacteria or fungi growth and to prevent degradation ... the material and its surface. It is used in ... preservation, food and beverage, paints and coatings. It is ... sanitizers, as well as in industrial applications to prevent ...
(Date:7/29/2014)... Crohn,s and Colitis Canada has invested $3.4 million ... disease and ulcerative colitis, debilitating chronic diseases that ... grants will support 9 promising research projects across ... environmental causes of the diseases, improve our understanding ... to improve patient care and quality of life. ...
(Date:7/29/2014)... materials capable of repelling bacteria have each won ... to find out why. , Their bacteria ... in hospital infections acquired through implanted medical devices ... across the globe. , Morgan Alexander, Professor of ... Paul Williams, Professor of Molecular Microbiology, in the ...
(Date:7/29/2014)... the increasing use of electronic medical records and ... for a computerized version of the preventive care ... a new study, researchers from the Indiana University ... that substantial work lies ahead to convert the ... computerized prompts for physicians, but the payoff has ...
(Date:7/29/2014)... -- The U.S. should significantly reform the federal ... to ensure that the public,s $15 billion annual ... needs, says a new report by the Institute ... through Medicare -- requires little accountability, allocates funds ... offers insufficient opportunities to train physicians in the ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Prestigious Crohn's and Colitis Canada grants fund promising Canadian research 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3
... Complex Rehab Market , , ... with 35 years of experience, has joined Alliance Seating ... complex rehab companies. O,Neill is an Assistive Technology Supplier ... and is responsible for sales and service of rehabilitation equipment ...
... 16 For the past 40 years, arc Thrift ... developmental,disabilities. This week, The Melvin and Elaine Wolf ... a Purpose" program. "As,one of the larger employers of ... partner with The Melvin and Elaine Wolf Foundation to ...
... a neurodegenerative disorder that causes the weakening of muscles, ... in 1 in 6,000 live births. While trans-splicing ... as a treatment for spinal muscular atrophy in cell-based ... the therapy to the human body. A University of ...
... The Journal of Nuclear Medicine SNM,s flagship publicationwill ... change to the publication allows the generous use of ... of research reports," said Heinrich R. Schelbert, M.D., editor ... . "Most important and critical, it strengthens the communication ...
... Mo. Evolving HIV viral strains and the adverse ... treatments propel scientists to continue exploring alternative HIV ... Missouri researcher has identified broad-spectrum aptamers. Aptamers are ... reproducing. In lab tests, aptamers known as RT5, ...
... autism are,struggling with a host of worries that impact ... their family will lack the life-long supports,needed to address ... released today by Easter Seals and made possible by ... Autism Study results reveal parents raising,children with autism are ...
Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:The Melvin and Elaine Wolf Foundation Donates $10,000 to arc Thrift Stores 2Health News:Journal of Nuclear Medicine premiers new, full-color design 2Health News:Researcher refining synthetic molecules to prevent HIV resistance 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 3Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 4Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 5Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: